Integrating Quality of Life in the Care Pathway of Cancer Patients Undergoing Immunotherapy Treatment: Descriptive, Cross-sectional Survey of an Online Patient Community's Experiences and Expectations

BACKGROUND: New cancer treatments, such as immune checkpoint inhibitors (ICIs), can improve survival and health-related quality of life (HRQoL) in patients with cancer. Although long-term monitoring of HRQoL has been shown to improve survival, integration of HRQoL into everyday practice remains poor...

Descripción completa

Detalles Bibliográficos
Autores principales: Wilczynski, Ophélie, Boisbouvier, Anthony, Radoszycki, Lise, Cotté, François-Emery, Gaudin, Anne-Françoise, Lemasson, Hervé
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2022
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790682/
https://www.ncbi.nlm.nih.gov/pubmed/35014969
http://dx.doi.org/10.2196/25792

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790682/
https://www.ncbi.nlm.nih.gov/pubmed/35014969
http://dx.doi.org/10.2196/25792

Ejemplares similares